Antibacterial Agents TRIZ Cases

Fusing VHH fragments with IgA Fc domains in Arabidopsis seeds creates stable antibodies that resist proteolysis and prevent bacterial colonization.

Water-soluble anionic bacteriochlorophyll derivatives accumulate selectively in tumor vasculature to enhance photodynamic therapy efficacy.

Thiophene-derived compounds inhibit acyl carrier protein synthase to disrupt bacterial lipid metabolism.

Benzazole compounds inhibit interleukin receptor associated kinases, addressing the lack of effective kinase inhibitors for treating inflammatory diseases.

Aminomethyl tryptanthrin derivative reduces IC50 values by modifying the chemical structure to resolve low inhibition efficiency.

Phosphate ester modifications increase tizoxanide blood concentration and half-life, resolving low absorption limits.

Formula I macrolides employ 3-hydroxy-naphthyridin-4-yl groups to boost activity against resistant strains while reducing drug interaction risks.

A composition of fatty acids and essential oils targets Borrelia sp. forms.

Piperidine-2,6-dione derivatives reduce toxicity while maintaining efficacy against inflammatory diseases.

Small molecules targeting the LuxO ATP binding pocket reduce virulence factor production and cytotoxicity without off-target effects.

C-terminal modifications alter protein conformation to reduce autoantibody binding, improving therapeutic safety profiles.

Bacteroides fragilis CCFM1020 modulates gut flora to resolve endotoxin infection trade-offs by regulating immune responses.

Inositol phosphate bonds silver ions to calcium compound surfaces.

Cholestanol-modified sulfated oligosaccharides enhance binding affinity to heparanase targets while reducing anticoagulant side effects.

Engineered chimeric polypeptides solve inefficient antigen loading by directing proteins onto exosomes across multiple cell types.

A liquid crystalline nanosuspension delivers therapeutic agents via mucoadhesive aqueous dispersion.

Monoclonal antibodies bind Staphylococcus aureus alpha-toxin to prevent cellular lysis and protect host tissues from cytotoxic damage.

Combines multiplex polymerase chain reaction with pooled antibiotic susceptibility testing to identify pathogens and resistance genes rapidly.

Additive fabrication merges jaw scanning with virtual positioning to produce one-piece braces, reducing production time and improving fit precision.

A subdermal needle electrode apparatus uses a constant force spring to maintain consistent pressure on the implant contact point.

Administering a live attenuated strain without O-antigen ligase function eradicates intracellular bacterial reservoirs while avoiding antimicrobial resistance.

Recombinant peptides with targeted amino acid mutations induce robust immune responses against Staphylococcus aureus virulence factors.

A bacteriophage cocktail reduces Salmonella populations in poultry and eggs through specific lytic activity against multiple serotypes.

Commensal bacteria inhibit Clostridium difficile toxin elaboration via proteolytic activity and Stickland fermentation, addressing recurrent infection risks.

ΦCJ8 bacteriophage lyses resistant Salmonella bacteria, bypassing antibiotic failure while preserving beneficial gut flora.

Oral delivery of IFNg-producing Lactococcus lactis reduces mortality and bacterial load while eliminating injection stress.

Arylpropionamide compounds selectively inhibit factor XIa serine protease enzymes.

Synthesizing antifungal compound 1 via morpholine amide reactions resolves the potency-selectivity trade-off by reducing off-target inhibition.

Pyrrolo[2,3-d]pyrimidin-2-one compounds bind bacterial ribosomes to inhibit protein synthesis and bypass resistance mechanisms.

Fusing multiple GBS59 clades into one polypeptide overcomes limited strain coverage in traditional vaccines by presenting diverse epitopes simultaneously.

Acidic solutions solubilize fluorocarbon-linked peptides into stable micelles, preventing aggregate formation and maintaining immunogenicity.

Lipid nanoparticles encapsulate recombinant human epidermal growth factor to provide sustained release, reducing adverse side effects from frequent dosing.

A topical gel combines six herbal extracts with salicylic acid to treat acne.

Merging simultaneous vaccination eliminates sequential intervals that leave piglets vulnerable to infection while maintaining protection efficacy.

Chemical bonding of peroxide to superabsorbent polymers stabilizes the agent, reducing cytotoxicity while maintaining antimicrobial efficacy against pathogens.

Aromatic amides modify the R3 position to enhance metabolic stability and efficacy against resistant strains while managing molecular complexity.

A MASP-2 inhibitory agent targets the lectin-dependent complement pathway to treat disseminated intravascular coagulation.

Indole derivatives inhibit TDO and IDO enzymes to lower kynurenine levels, alleviating immunosuppression and restoring immune function against tumors.

Consensus peptide sequences bind chondroitin-4-sulfate proteoglycans to deliver cargo into cells while resisting protease degradation.

1-Methylnicotinamide reduces serum C-reactive protein levels, enabling accurate cardiovascular risk prediction in non-dyslipidemic patients.

Shigella GMMA vaccine compositions utilize modified lipid A structures to enhance immunogenicity while minimizing reactogenicity in target populations.

Covalent bispecific diabodies link polypeptide chains via peptide bonds to form stable antigen-binding structures.

Small molecule antagonists replace complex protein therapies by suppressing MCP-1 induced monocyte migration in inflammatory diseases.

Formula I compounds inhibit Staphylococcus pathogens via DXR enzyme targeting, improving bioavailability and serum half-life over fosmidomycin.